Literature DB >> 10585866

Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity.

H Takahashi1, K Asano, S Nakamura, A Ishida-Yamamoto, H Iizuka.   

Abstract

Involucrin is one of the precursor proteins of the cornified cell envelope of keratinocytes, and is expressed during the later stages of keratinocyte differentiation. Interferon-gamma (IFN-gamma), a pleiotropic cytokine with anti-proliferative and immunomodulatory activities, is also a potent inducer of squamous differentiation. Using cultured normal human keratinocytes (NHK cells) and simian virus 40-transformed human keratinocytes (SVHK cells), we investigated the effects of IFN-gamma on involucrin gene expression. Expression of involucrin was increased by about 3-fold after treating NHK cells with IFN-gamma (100 units/ml). Northern blot analyses revealed that IFN-gamma increased the expression of involucrin mRNA. The fragment +42 to -2463 in the 5'-flanking region of the human involucrin gene was subcloned into a luciferase reporter vector and the construct (p2463Luc) was transfected into SVHK cells. p2463Luc produced a 3-fold increase in luciferase activity after IFN-gamma treatment. Sequence analysis detected two putative IFN-gamma-responsive regions [G1 (positions -883 to -874) and G2 (-784 to -775)]. Deletion analyses of the p2463Luc vector revealed that the G1 region is critical for the IFN-gamma-dependent up-regulation of the involucrin gene. Gel-shift analyses revealed that STAT1 (signal transduction and activators of transcription 1) protein bound to the G1 region and that involucrin promoter activity was augmented by transfection of a STAT1 expression vector in the presence of IFN-gamma. In contrast, transfection of a STAT1 dominant-negative expression vector suppressed the IFN-gamma-dependent up-regulation of involucrin promoter activity. These results indicate that IFN-gamma stimulates expression of the human involucrin gene via the G1 (-883 to -874) region of the involucrin gene promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585866      PMCID: PMC1220701     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope.

Authors:  P M Steinert; L N Marekov
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

2.  Distribution of interferon-gamma receptors in normal and psoriatic skin.

Authors:  J J van den Oord; M De Ley; C De Wolf-Peeters
Journal:  Pathol Res Pract       Date:  1995-07       Impact factor: 3.250

3.  Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity.

Authors:  J F Welter; J F Crish; C Agarwal; R L Eckert
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

Review 5.  Involucrin--structure and role in envelope assembly.

Authors:  R L Eckert; M B Yaffe; J F Crish; S Murthy; E A Rorke; J F Welter
Journal:  J Invest Dermatol       Date:  1993-05       Impact factor: 8.551

6.  T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.

Authors:  S Vollmer; A Menssen; P Trommler; D Schendel; J C Prinz
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

7.  Analysis of the 5'-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  H Takahashi; H Iizuka
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

8.  Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1).

Authors:  H Takahashi; H Kobayashi; S Matsuo; H Iizuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  Transcriptional analysis of the 5'-noncoding region of the human involucrin gene.

Authors:  E Lopez-Bayghen; A Vega; A Cadena; S E Granados; L F Jave; P Gariglio; L M Alvarez-Salas
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

10.  Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1.

Authors:  N A Saunders; A M Jetten
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

View more
  5 in total

1.  Entrapment of conjunctival goblet cells by desiccation-induced cornification.

Authors:  Rosa Maria Corrales; Cintia Sade de Paiva; De-Quan Li; William Johnson Farley; Johanna Tukler Henriksson; Jan Per Gustav Bergmanson; Stephen Carl Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes.

Authors:  Divya Ramnath; Kathryn Tunny; Daniel M Hohenhaus; Claire M Pitts; Anne-Sophie Bergot; P Mark Hogarth; John A Hamilton; Ronan Kapetanovic; Richard A Sturm; Glen M Scholz; Matthew J Sweet
Journal:  Immunol Cell Biol       Date:  2015-08-25       Impact factor: 5.126

3.  Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.

Authors:  Shimin Li; Marianne Gallup; Ying-Ting Chen; Nancy A McNamara
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

Review 4.  Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.

Authors:  Christophe Baudouin; Elisabeth M Messmer; Pasquale Aragona; Gerd Geerling; Yonca A Akova; José Benítez-del-Castillo; Kostas G Boboridis; Jesús Merayo-Lloves; Maurizio Rolando; Marc Labetoulle
Journal:  Br J Ophthalmol       Date:  2016-01-18       Impact factor: 4.638

Review 5.  Interferons and Dry Eye in Sjögren's Syndrome.

Authors:  Yoko Ogawa; Eisuke Shimizu; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2018-11-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.